REGENXBIO Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

REGENXBIO Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $170.44 million for the year ending 2025.

  • REGENXBIO Inc. showed an increase of +104.5% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), REGENXBIO Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 3,614.1%.
  • Historical annual values: Fiscal year 2025: $170.44 million | Fiscal year 2024: $83.33 million | Fiscal year 2023: $90.24 million | Fiscal year 2022: $112.72 million | Fiscal year 2021: $470.35 million | Fiscal year 2020: $154.57 million | Fiscal year 2019: $35.23 million | Fiscal year 2018: $218.51 million | Fiscal year 2017: $10.39 million | Fiscal year 2016: $4.59 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: